Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 16C2H5NO2.5I2.4HI |
| Molecular Weight | 2981.7599 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
I.I.I.I.II.II.II.II.II.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O.NCC(O)=O
InChI
InChIKey=MHTIPMQDAXVYJV-UHFFFAOYSA-N
InChI=1S/16C2H5NO2.5I2.4HI/c16*3-1-2(4)5;5*1-2;;;;/h16*1,3H2,(H,4,5);;;;;;4*1H
| Molecular Formula | I2 |
| Molecular Weight | 253.8089 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C2H5NO2 |
| Molecular Weight | 75.0666 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HI |
| Molecular Weight | 127.9124 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tetraglycine hydroperiodide is an iodine-containing chemical, used for water purification. Tetraglycine hydroperiodide is marketed in tablets; each tablet effectively disinfects 1 liter of clear water or 0.5 liter of tainted water by releasing approximately 8 mg free iodine. It requires approximately 30 minutes to inactivate target microorganisms and make water bacteriologically suitable for drinking. To remove iodine taste, a vitamin C pill is added to the kit.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The susceptibility of the fetus and child to chemical pollutants. Special susceptibility of the host to chemical agents: endocrinologic considerations. | 1974 May |
|
| [Necrotizing hepatitis with a fatal outcome after carbimazole therapy]. | 1993 Oct 22 |
|
| Subfulminant hepatitis requiring liver transplantation after benzarone administration. | 1994 Jun |
|
| Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. | 1995 Jan |
|
| Case report: reversible mitral regurgitation and congestive heart failure complicating thyrotoxicosis. | 1996 Mar |
|
| Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. | 1997 Jul |
|
| Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs. | 1998 Jul |
|
| Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy. | 1999 Sep-Oct |
|
| Anti-goitrous effect of lecithin-bound iodine in propylthiouracil treated rats. | 2000 Jun |
|
| Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. | 2001 Feb |
|
| Effects of selenium and iodine on the expression of c-fos and c-jun mRNA and their proteins in cultured rat hippocampus neurons. | 2002 Jun |
|
| Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. | 2005 Oct |
|
| Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation. | 2006 Aug 1 |
|
| Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. | 2006 Jul |
|
| Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. | 2006 Jul 14 |
|
| Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. | 2006 Nov-Dec |
|
| The treatment of Graves' disease in children. | 2006 Sep |
|
| Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. | 2007 Apr |
|
| Goiter and other iodine deficiency disorders: A systematic review of epidemiological studies to deconstruct the complex web. | 2007 Jan |
|
| [Effects of iodine excess and selenium supplement on the levels of thyroid hormone and its receptor expression in filial cerebrum of mice]. | 2007 Mar |
|
| Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment. | 2007 Mar |
|
| Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). | 2007 Nov |
|
| Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. | 2007 Oct 1 |
|
| [Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media]. | 2008 |
|
| Gadolinium and kidney disease: are your patients at risk? | 2008 Mar-Apr |
|
| A blinded, randomized, palatability study comparing variations of 2 popular field water disinfection tablets. | 2011 Dec |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:07 GMT 2023
by
admin
on
Fri Dec 15 15:51:07 GMT 2023
|
| Record UNII |
T7Y820X70C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
46923
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID0048058
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
PRIMARY | |||
|
7097-60-1
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
PRIMARY | |||
|
76970979
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
PRIMARY | |||
|
T7Y820X70C
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
PRIMARY | |||
|
m10622
Created by
admin on Fri Dec 15 15:51:07 GMT 2023 , Edited by admin on Fri Dec 15 15:51:07 GMT 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
